Receptos, Inc.
  • home
  • about
    • executive team
    • board of directors
    • scientific founders
    • scientific advisory board
    • clinical advisory board
    • investors
  • clinical
    pipeline
    • RPC1063
    • S1P1 additional indications
    • what is multiple
      sclerosis (MS)?
  • research &
    technology
    • information-driven drug design for G protein-coupled receptors (GPCRs)
    • untapped potential in the GPCR superfamily
    • small molecule GLP-1 agonist program for type 2 diabetes
  • corporate partnering
    • corporate fact sheet
  • news & publications
    • news
    • publications
  • contact
    • directions
    • careers
  • news
    • press releases
    • in the news
  • publications
    • S1P1
    • Structural Biology

news & publications

In The News

TVG
August, 2011
TVG Success Story: Receptos and Lilly - Sometimes a chance meeting
really does turn into a deal
BioCentury
February, 2011
Receptos: Designs Against GPCRs
Start-Up
February, 2011
Rapid-fire reception for a GPCR platform
Xconomy
January, 2011
Receptos Cuts Deals with J&J, Lilly
Xconomy
December, 2010
Receptos Hires New CEO, Former Facet Leader, as Rastetter Moves Upstairs
The Pink Sheet
November, 2009
Newly-Funded Receptos Bets On The Safety Of Its Oral MS Drug
BioWorld Today
November, 2009
Receptos Starts with $25M Funding, GPCR Dream Team
  • terms of use
  • privacy
  • home
  • about
  • clinical pipeline
  • research & technology
  • corporate partnering
  • contact
© 2012 Receptos, Inc. All Rights Reserved.